A Multicentre, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis

  • Hodge, Alex, (Primary Chief Investigator (PCI))

Project: Research

Project Description

NMA Reference Number: HREC/16/SVHM/78
SSA Reference Number: SSA/16/MonH/329
Monash Health HREC Ref: RES-16-0000-488X
StatusActive
Effective start/end date1/07/19 → 30/06/24
View all
View less

Keywords

  • clinical trial
  • treatment efficacy
  • hepatitis
  • fibrosis
  • clinical trial
  • treatment efficacy
  • hepatitis
  • fibrosis
  • clinical trial
  • treatment efficacy
  • hepatitis
  • fibrosis